Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Anna Woodson

Dermatology Gainesville, GA Medical Doctor

NPI 1427250935 CMS profile 660363

1488 Jesse Jewell Pkwy Se Ste 202, Gainesville, GA 30501

Open in the dashboard

General payments

$4,234

205 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Anna Woodson of Gainesville, GA is reported in the CMS Open Payments database as having received $4,234 across 205 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 61st percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $580 27
2024 General $831 39
2023 General $1,516 66
2022 General $539 29
2021 General $310 18
2020 General $123 7
2019 General $335 19

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Anna Woodson
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Anna Woodson were reported at $580. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Anna Woodson Dermatology median Middle half National median
2019 $335 $454 $129–$1,240 $163
2020 $123 $235 $81–$756 $114
2021 $310 $377 $108–$1,108 $132
2022 $539 $514 $143–$1,391 $149
2023 $1,516 $607 $159–$1,674 $160
2024 $831 $751 $204–$1,903 $164
2025 $580 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $991 45 payments
  2. UCB, Inc. $524 26 payments
  3. Genzyme Corporation $320 12 payments
  4. Galderma Laboratories, L.P. $301 13 payments
  5. Janssen Biotech, Inc. $285 14 payments
  6. Regeneron Healthcare Solutions, Inc. $279 12 payments
  7. Incyte Corporation $236 26 payments
  8. Sun Pharmaceutical Industries Inc. $218 12 payments
  9. Pfizer Inc. $215 7 payments
  10. Dermavant Sciences, Inc. $197 4 payments
  11. Other $669 34 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,096 200 payments
  2. Education $139 5 payments
Products named General payments · program years 2019–2025
  1. Cimzia $408 20 payments
  2. DUPIXENT Immunology $331 13 payments
  3. SKYRIZI $320 21 payments
  4. TREMFYA $258 12 payments
  5. OPZELURA $236 26 payments
  6. RINVOQ $234 6 payments
  7. NEMLUVIO $207 7 payments
  8. VTAMA $197 4 payments
  9. DUPIXENT Inflammation And Immunology $190 8 payments
  10. CIBINQO $189 5 payments
  11. Other $1,743 94 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 19 drugs

Part D claims

854

Median for Dermatology: 534

Drug cost

$78,907

Median for Dermatology: $67,151

Branded share of claims

3.2%

Median for Dermatology: 8.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Dupixent Pen Dupilumab Brand 14 $52,288
Tacrolimus Generic 52 $7,513
Clobetasol Propionate Generic 117 $4,257
Fluorouracil Generic 48 $3,662
Clindamycin Phosphate Generic 55 $1,901
Fluocinonide Generic 54 $1,842
Ketoconazole Generic 133 $1,794
Triamcinolone Acetonide Generic 80 $1,003
Doxycycline Hyclate Generic 52 $913
Metronidazole Generic 26 $862

The 10 drugs with the highest cost, of 19 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,550 Part D prescribers listed as Dermatology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 37 billing codes

Paid by Medicare

$70,242

Medicare's payments for the services billed

Medicare patients

340

Average age 73

Services billed

1,690

192 women, 148 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 73%
Arthritis 46%
Ischemic heart disease 28%
Chronic kidney disease 28%
Diabetes 26%
Depression 22%
Atrial fibrillation 16%
COPD 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 12 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
RINVOQ
  • AbbVie, Inc. $171
$171 — —
SKYRIZI
  • AbbVie, Inc. $170
$170 — —
DUPIXENT
  • GENZYME CORPORATION $69
  • Regeneron Healthcare Solutions, Inc. $54
$123 14 —
SOTYKTU
  • E.R. Squibb & Sons, L.L.C. $67
$67 — —
Bimzelx
  • UCB, Inc. $54
$54 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 12 in the dashboard with a free account

Records

205 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record